P2RY12 and angina pectoris: Prasugrelis a P2Y12 platelet inhibitor used to reduce the risk of thrombotic cardiovascular events in unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and in patients with STEMI when managed with either primary or delayed PCI.